FORM 8-A
                                     
                    SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C.  20549
                                     
                         _________________________
                                     
             FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                  PURSUANT TO SECTION 12(b) OR (g) OF THE
                      SECURITIES EXCHANGE ACT OF 1934
                                     
                                     
                        QUAKER CHEMICAL CORPORATION
          ------------------------------------------------------
          (Exact name of registrant as specified in its charter)
                                     
                                     
                                     
                  Pennsylvania                        23-0993790
    -------------------------------------------------------------------
      (State of incorporation or organization)      (I.R.S. Employer
                                                   Identification No.)

        Elm and Lee Streets
       Conshohocken, Pennsylvania                        19428
- ------------------------------------------------------------------------
(Address of principal executive offices)               (Zip Code)


Securities to be registered pursuant to Section 12(b) of the Act:

     Title of each class                     Name of each exchange on which
      to be registered                       each class is to be registered
     -------------------                     ------------------------------
Common Stock Purchase Rights                    New York Stock Exchange
with respect to Common Stock,
$1 Par Value




Securities to be registered pursuant to Section 12(g) of the Act:


                              None
- ---------------------------------------------------------------------------
                        (Title of Class)


Item 1.   Description of Securities to be Registered.
          -------------------------------------------

     On February 7, 1990, the Board of Directors of Quaker Chemical
Corporation (the "Company") declared a dividend distribution of one Right
for each outstanding share of the Company's Common Stock to Shareholders of
record at the close of business on February 20, 1990.  Each Right entitles
the registered holder to purchase from the Company one one-hundredth of a
share of the Company's Series A Preferred stock (the "Preferred Stock") at
a purchase price of $72, subject to further adjustment.  The description
and terms of the Rights are set forth in a Rights Agreement between the
Company and American Stock Transfer and Trust Company, as Rights Agent (the
"Rights Agreement").

     Initially, the Rights attach to all shares of Common Stock, and no
separate Rights Certificates will be distributed.  The Rights will separate
from the Common Stock on the Distribution Date.  The "Distribution Date" is
defined as the earlier of (i) 10 days following a public announcement that
a person or group of affiliated or associated persons (an "Acquiring
Person") has acquired, or obtained the right to acquire, beneficial
ownership of 20% or more of the outstanding shares of Common Stock (the
"Stock Acquisition Date"), (ii) 10 business days following the commencement
of a tender offer or exchange offer that would result in a person or group
beneficially owning 20% or more of the outstanding shares of Common Stock,
or (iii) 10 business days after the Board of Directors of the Company (the
"Board") determines any person, alone or together with affiliates and
associates, has become the beneficial owner of an amount of Common Stock
which the Board determines to be substantial (which amount shall in no
event be less than 10% of the outstanding shares of Common Stock) and at
least a majority of the Board, who are not officers of the Company,
determine that (a) such beneficial ownership by such person is intended to
cause the Company to repurchase the Common Stock beneficially owned by such
person or to cause pressure on the Company to take action or enter into a
transaction or series of transactions intended to provide such person with
short-term financial gain under circumstances where the Board determines
that the best long-term interests of the Company and its shareholders would
not be served by taking such action or entering into such transactions or
series of transactions at that time or (b) such beneficial ownership is
causing or reasonably likely to cause a material adverse impact (including,
but not limited to, impairment of relationships with customers or
impairment of Company's ability to maintain its competitive position) on
the business or prospects of the Company (any such person being an "Adverse
Person").


     Until the Distribution Date, (i) the Rights will be evidenced by the
Common Stock certificates and will be transferred only with such Common
Stock certificates, (ii) Common Stock certificates issued after February
20, 1990 contain a legend incorporating the Rights Agreement by reference,
and (iii) the surrender for transfer of any certificates for Common Stock
will also constitute the transfer of the Rights associated with the Common
Stock represented by such certificate.

     The Rights are not exercisable until the Distribution Date and will
expire at the close of business on February 20, 2000, unless earlier
redeemed or exchanged by the Company as described below.

     As soon as practicable after the Distribution Date, Rights
Certificates will be mailed to holders of record of the Common Stock as of
the close of business on the Distribution Date and, thereafter, the Rights
Certificates alone will represent the Rights.  Except as otherwise
determined by the Board, only shares of Common Stock issued prior to the
Distribution Date will be issued with Rights.

     In the event that the Board determines that a person is an Adverse
Person or a person becomes an Acquiring Person (except pursuant to an offer
for all outstanding shares of Common Stock which the independent Directors
determine to be fair to and otherwise in the best interests of the Company
and its shareholders), each holder of a Right will thereafter have the
right to receive, upon exercise, Common Stock (or, in certain
circumstances, cash, property or other securities of the Company) having a
value equal to two times the exercise price of the Right.  If a Person is
declared an Adverse Person or becomes an Acquiring Person, all Rights that
are, or (under certain circumstances specified in the Rights Agreement)
were, beneficially owned by such Person will be null and void.

     In the event that, at any time following the Stock Acquisition Date,
(i) the Company is acquired in a merger or other business combination
transaction in which the Company is not the surviving corporation, or (ii)
50% or more of the Company's assets or earning power is sold or
transferred, each holder of a Right (except Rights which are null and void)
shall thereafter have the right to receive, upon exercise, common stock of
the acquiring company having a value equal to two times the exercise price
of the Right.

     The Purchase Price payable, and the number of one-hundredth shares of
the Preferred Stock or other securities or property issuable, upon exercise
or exchange of the Rights are subject to adjustment from time to time to
prevent dilution as specified in the Rights Agreement.


     In general, the Company may redeem the Rights in whole, but not in
part, at a price of $.01 per Right, at any time until the Stock Acquisition
Date.  Immediately upon the action of the Board authorizing a redemption of
the Rights, the Rights will terminate and the only right of the holders of
Rights will be to receive the redemption price.  In addition, the Company
may at a time after a person becomes an Acquiring Person or Adverse Person,
but prior to a person acquiring 50% of the outstanding shares of Common
Stock, exchange the Rights (except Rights which are null and void) in whole
or in part, at an exchange ratio of one share of Common Stock or one one-
hundredth of a share of Preferred Stock per Right.

     Until a Right is exercised, the holder will have no rights as a
shareholder of the Company, including, without limitation, the right to
vote or to receive dividends.

     Other than those provisions relating to the principal economic terms
of the Rights, any of the provisions of the Rights Agreement may be amended
by the Board prior to the Distribution Date.  After the Distribution Date,
the provisions of the Rights Agreement may be amended by the Board in order
to cure any ambiguity, to make changes which do not adversely affect the
interests of holders of Rights (excluding the interests of any Acquiring
Person, Adverse Person or any affiliate or associate of such person), or to
shorten or lengthen any time period under the Rights Agreement; provided,
however, that no amendment to adjust the time period governing redemption
shall be made at such time as the Rights are not redeemable.

     As long as the Rights are attached to the Common Stock, one Right
shall be deemed to be delivered for each share of Common Stock issued or
transferred by the Company.  Following the Distribution Date and prior to
the expiration or redemption of the Rights, the Company, in general, will
issue one Right for each share of Common Stock issued pursuant to the
exercise of stock options or under employee plans or upon the exercise,
conversion or exchange of certain securities of the Company.  In any other
case, after the Distribution Date, the Company may issue Rights when it
issues Common Stock, if the Board deems it to be necessary or appropriate.
One hundred thousand shares of Preferred Stock are initially reserved for
issuance upon exercise of the Rights, such number to be subject to
adjustment from time to time in accordance with the Rights Agreement.


     The Rights have certain anti-takeover effects.  The Rights will cause
substantial dilution to a person or group that attempts to acquire the
Company without conditioning the offer on a substantial number of Rights
being acquired.  The Rights will not interfere with any merger or other
business combination approved by the Board since the Board may, at its
option, at any time until ten days following the Stock Acquisition Date
redeem all but not less than all the then outstanding Rights at the
Redemption Price.  Notwithstanding the foregoing, the Board may not redeem
the outstanding Rights if it has previously declared any person to be an
Adverse Person.  In such event, the Rights could interfere with any merger
or other business combination approved by the Board.

     The Rights Agreement between the Company and the Rights Agent
specifying the terms of the Rights is an exhibit to this Registration
Statement and is incorporated herein by reference. The foregoing
description of the Rights does not purport to be complete and is qualified
in its entirety by reference to the Rights Agreement and the exhibits
thereto.

Item 2.   Exhibits.
          ---------

     1.   Rights Agreement dated as of February 7, 1990 as filed as an
          exhibit to Form 8-A filed by Registrant on February 20, 1990 is
          incorporated herein by reference.

     2.   All exhibits required by Instruction II to Item 2 will be
          supplied to the New York Exchange.


                                     
                                SIGNATURES
                                ----------

     Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this Registration Statement to
be signed on its behalf by the undersigned, thereunto duly authorized.


                                        QUAKER CHEMICAL CORPORATION
                                        -----------------------------------
                                                  (Registrant)


Dated:  July 31, 1996                   By: /s/ Karl H. Spaeth
                                           --------------------------------
                                           Karl H. Spaeth,
                                           Corporate Secretary